Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genop Healthcare is a South African specialty healthcare marketing and distribution company focused on eye care, skincare and aesthetics. The company operates through business units including Epi-max, Skincare & Aesthetics, and Eye Care, and commercializes a portfolio of ophthalmic instruments, ophthalmic surgical products, pharmaceuticals, and dermatology-related products. It appears to function primarily as a commercial-stage distributor and brand owner/marketer rather than a drug discovery biotech with an internal clinical pipeline. Genop Healthcare is owned by Adcock Ingram and serves healthcare professionals in South Africa, particularly in ophthalmology, optometry, medical aesthetics, and related clinical settings. Its business is centered on commercialization, agency/distribution relationships, and supply of established healthcare products rather than novel therapeutic R&D.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genop Healthcare.